Cerebral Amyloid Angiopathy: A Systematic Review

• Published in: Journal of clinical neurology (Seoul, Korea) Vol. 7; no. 1; pp. 1 - 9
• Main Authors: Biffi, Alessandro, Greenberg, Steven M.
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Neurological Association 01.03.2011; 대한신경과학회
• Subjects: Review; 신경과학; cerebral amyloid angiopathy; dementia; cerebral hemorrhage
• ISSN: 1738-6586; 2005-5013; 2005-5013
• DOI: 10.3988/jcn.2011.7.1.1

Cerebral amyloid angiopathy (CAA) is a disorder characterized by amyloid deposition in the walls of leptomeningeal and cortical arteries, arterioles, and less often capillaries and veins of the central nervous system. CAA occurs mostly as a sporadic condition in the elderly, its incidence associating with advancing age. All sporadic CAA cases are due to deposition of amyloid-β, originating from proteolytic cleavage of the Amyloid Precursor Protein. Hereditary forms of CAA are generally familial (and therefore rare in the general population), more severe and earlier in onset. CAA-related lobar intracerebral hemorrhage is the most well-studied clinical condition associated with brain amyloid deposition. Despite ever increasing understanding of CAA pathogenesis and availability of reliable clinical and diagnostic tools, preventive and therapeutic options remain very limited. Further research efforts are required in order to identify biological targets for novel CAA treatment strategies. We present a systematic review of existing evidence regarding the epidemiology, genetics, pathogenesis, diagnosis and clinical management of CAA.